Skip to main content
. Author manuscript; available in PMC: 2023 Oct 19.
Published in final edited form as: Parkinsonism Relat Disord. 2023 Oct 2;116:105866. doi: 10.1016/j.parkreldis.2023.105866

Table 1B. Clinical and demographic characteristics of the study population with pathological confirmation of diagnosis split by disease phenotype.

PSP-RS PSP-C PSP-SC PSP-C vs PSP-RS PSP-C vs PSP-SC PSP-RS vs PSP-SC
N=30 N=12 N=7 p-value p-value p-value
Sex, Male/Female (%) 0.53 (0.51) 0.50 (0.52) 0.43 (0.53) 1.000 1.000 1.000
Age at symptom onset 65.8 (6.85) 67.8 (9.52) 62.7 (8.29) 0.735 0.362 0.613
Age at diagnosis 69.4 (6.97) 70.8 (9.09) 68.7 (6.74) 0.843 0.824 0.974
Age at scan 70.0 (6.95) 72.2 (8.64) 69.1 (6.96) 0.657 0.657 0.958
Age at death 72.7 (6.44) 74.5 (7.77) 71.4 (6.34) 0.715 0.602 0.892
Duration from symptom onset to diagnosis 3.62 (2.53) 3.06 (1.77) 6.02 (4.96) 0.630 0.260 0.220
Duration from symptom onset to scan 4.22 (2.79) 4.45 (2.34) 6.44 (5.31) 0.520 0.540 0.530
Total disease duration (symptom onset to death) 6.91 (2.57) 6.73 (3.74) 8.71 (5.26) 0.210 0.650 0.690
Duration from diagnosis to death 3.29 (1.66) 3.68 (3.01) 2.68 (1.48) 0.750 0.650 0.340
Survival from scan 2.69 (1.59) 2.29 (1.84) 2.26 (1.34) 0.280 1.000 0.490
Temporal Stage 0.60 (0.20) 0.67 (0.18) 0.67 (0.17) 0.566 0.998 0.642
PSP Rating Scale 39.0 (15.2) 38.4 (17.5) 43.0 (14.9) 0.997 0.914 0.910
Scan to PSP Rating Scale (days) 21.3 (22.8) 35.8 (34.9) 35.0 (35.0) 0.336 0.881 0.517
Phenotype
         PSP-CBS 0 6 (50%) 0
         PSP-F 0 3 (25%) 0
         PSP-P 0 0 2 (29%)
         PSP-PGF 0 0 1 (14%)
         PSP-PI 0 0 4 (57%)
         PSP-RS 30 (100%) 0 0
         PSP-SL 0 3 (25%) 0

Abbreviations: PSP = progressive supranuclear palsy, PSP-C = PSP-Cortical, PSP-CBS = PSP corticobasal syndrome, PSP-F = PSP frontal, PSP-P = PSP parkinsonism, PSP-PGF = PSP progressive gait freezing, PSP-PI = PSP postural instability, PSP-RS = PSP-Richardson’s syndrome, PSP-SC = PSP-Subcortical, PSP-SL = speech and language.